TD SYNNEX Benefit from Receivables decreased by 48.9% to $6.83M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 7.3%, from $6.37M to $6.83M. Over 3 years (FY 2021 to FY 2025), Benefit from Receivables shows an upward trend with a 66.9% CAGR.
csco_benefit_from_receivables| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.78M | $3.00K | -$10.22M | $15.93M | $8.57M | $1.78M | $8.47M | $5.90M | $13.61M | $10.83M | $14.40M | $11.19M | $6.37M | $4.58M | $10.77M | $13.36M | $6.83M |
| QoQ Change | — | -99.8% | <-999% | +255.8% | -46.2% | -79.2% | +376.4% | -30.4% | +130.8% | -20.5% | +33.0% | -22.3% | -43.1% | -28.1% | +135.2% | +24.1% | -48.9% |
| YoY Change | — | — | — | — | +382.5% | >999% | +182.9% | -63.0% | +58.9% | +508.9% | +70.0% | +89.8% | -43.1% | — | — | — | +7.3% |